SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009334
Filing Date
2022-05-11
Accepted
2022-05-11 16:12:28
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rani-20220331.htm   iXBRL 10-Q 1656024
2 EX-10.2 rani-ex10_2.htm EX-10.2 54916
3 EX-31.1 rani-ex31_1.htm EX-31.1 13950
4 EX-31.2 rani-ex31_2.htm EX-31.2 13975
5 EX-32.1 rani-ex32_1.htm EX-32.1 8740
  Complete submission text file 0000950170-22-009334.txt   7152156

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rani-20220331_def.xml EX-101.DEF 328902
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rani-20220331_cal.xml EX-101.CAL 36395
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20220331_lab.xml EX-101.LAB 510595
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20220331.xsd EX-101.SCH 61467
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20220331_pre.xml EX-101.PRE 425166
59 EXTRACTED XBRL INSTANCE DOCUMENT rani-20220331_htm.xml XML 1086470
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40672 | Film No.: 22913859
SIC: 2834 Pharmaceutical Preparations